Investigators from the Smidt Heart Institute at Cedars-Sinai validated the link between a debilitating heart condition and COVID-19 and, to a lesser extent, a novel link between the same condition and COVID-19 vaccination.
Dec 12, 2022
0
82
Data from 4,099 participants of the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) has revealed that an increase in daily TV-watching time is significantly associated with an increase in bodily pain severity over ...
Dec 12, 2022
0
274
There's even more reason to think a vaccine developed against smallpox can help the body fight against mpox (monkeypox virus disease) as well, according to researchers at La Jolla Institute for Immunology (LJI). Their new ...
Dec 7, 2022
0
162
Should I get another booster? And if so, which vaccine should be used?
Dec 6, 2022
0
92
Researchers from the Institut Pasteur, Inserm, St. James's Hospital Dublin and Trinity are getting closer to understanding what makes some people so vulnerable to COVID-19-induced illness, which in turn may guide the development ...
Dec 1, 2022
0
49
Scientists at the Francis Crick Institute have uncovered how a build-up of DNA molecules can impact survival chances in people with severe COVID-19 or sepsis, and have developed a tool that could be used to identify the patients ...
Nov 17, 2022
0
31
Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus.
Nov 16, 2022
0
92
A definitive diagnosis of Alzheimer's disease (AD) was once only possible after someone had died, but recent biomarker studies have led to the development of imaging and spinal fluid tests for those still living. However, ...
Nov 9, 2022
0
53
Early diagnosis of chronic kidney disease (CKD) is key to managing progression of the disease. A new technique analyzing urine extracellular vesicles (uEVs)—cell-derived nanoscale spherical structures involved in multiple ...
Nov 8, 2022
0
43
Experiments involving animals and human cells conducted at the University of São Paulo (USP) in Brazil suggest that niclosamide, an anthelmintic widely used against tapeworms, effectively inhibits SARS-CoV-2 replication ...
Oct 21, 2022
0
54
